Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $7.2850 (-3.45%) ($7.2850 - $7.2850) on Thu. Dec. 24, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.32% (three month average) | RSI | 68 | Latest Price | $7.2850(-3.45%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -2.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 3.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(43%) IBB(38%) IWO(37%) IWC(36%) IWM(36%) | Factors Impacting BCRX price | BCRX will decline at least -2.66% in a week (0% probabilities). VIXM(-19%) UUP(-13%) VXX(-8%) IGOV(-4%) EDOC(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.66% (StdDev 5.32%) | Hourly BBV | -2.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.83(-6.96%) | 10 Day Moving Average | $8.04(-9.39%) | 20 Day Moving Average | $7.15(1.89%) | To recent high | -14.5% | To recent low | 44.7% | Market Cap | $1.285b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |